These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 25046528

  • 1. Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells.
    Frasco MF, Almeida GM, Santos-Silva F, Pereira Mdo C, Coelho MA.
    J Biomed Mater Res A; 2015 Apr; 103(4):1476-84. PubMed ID: 25046528
    [Abstract] [Full Text] [Related]

  • 2. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V, Denora N, Lopalco A, Lopedota A, Cutrignelli A, Lasorsa FM, Agostino G, Franco M.
    Mol Pharm; 2014 Mar 03; 11(3):859-71. PubMed ID: 24410438
    [Abstract] [Full Text] [Related]

  • 3. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
    Surassmo S, Saengkrit N, Ruktanonchai UR, Suktham K, Woramongkolchai N, Wutikhun T, Puttipipatkhachorn S.
    Colloids Surf B Biointerfaces; 2015 Jun 01; 130():229-36. PubMed ID: 25937384
    [Abstract] [Full Text] [Related]

  • 4. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
    Park JH, Lee JY, Termsarasab U, Yoon IS, Ko SH, Shim JS, Cho HJ, Kim DD.
    Int J Pharm; 2014 Oct 01; 473(1-2):426-33. PubMed ID: 25079433
    [Abstract] [Full Text] [Related]

  • 5. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B, Ranganathan B, Feng SS.
    Biomaterials; 2008 Feb 01; 29(4):475-86. PubMed ID: 17953985
    [Abstract] [Full Text] [Related]

  • 6. A transferrin variant as the targeting ligand for polymeric nanoparticles incorporated in 3-D PLGA porous scaffolds.
    Lopes AM, Chen KY, Kamei DT.
    Mater Sci Eng C Mater Biol Appl; 2017 Apr 01; 73():373-380. PubMed ID: 28183621
    [Abstract] [Full Text] [Related]

  • 7. Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.
    Thasneem YM, Sajeesh S, Sharma CP.
    Colloids Surf B Biointerfaces; 2013 Aug 01; 108():337-44. PubMed ID: 23563302
    [Abstract] [Full Text] [Related]

  • 8. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.
    Pandey SK, Patel DK, Maurya AK, Thakur R, Mishra DP, Vinayak M, Haldar C, Maiti P.
    Int J Biol Macromol; 2016 Aug 01; 89():99-110. PubMed ID: 27112980
    [Abstract] [Full Text] [Related]

  • 9. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT.
    J Biomed Mater Res A; 2012 Aug 01; 100(8):1998-2005. PubMed ID: 22566409
    [Abstract] [Full Text] [Related]

  • 10. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
    Thamake SI, Raut SL, Gryczynski Z, Ranjan AP, Vishwanatha JK.
    Biomaterials; 2012 Oct 01; 33(29):7164-73. PubMed ID: 22795543
    [Abstract] [Full Text] [Related]

  • 11. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
    Li R, Zhang Q, Wang XY, Chen XG, He YX, Yang WY, Yang X.
    Drug Res (Stuttg); 2014 Oct 01; 64(10):541-7. PubMed ID: 24443309
    [Abstract] [Full Text] [Related]

  • 12. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X, Zhu Q, Sun Y, Li L, Zhu Y, Zhao Z, Zuo J, Fang W, Li K.
    Int J Mol Med; 2015 Apr 01; 35(4):995-1002. PubMed ID: 25672594
    [Abstract] [Full Text] [Related]

  • 13. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
    Wang ZQ, Liu K, Huo ZJ, Li XC, Wang M, Liu P, Pang B, Wang SJ.
    J Nanobiotechnology; 2015 Oct 01; 13():63. PubMed ID: 26427800
    [Abstract] [Full Text] [Related]

  • 14. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile.
    Alam N, Khare V, Dubey R, Saneja A, Kushwaha M, Singh G, Sharma N, Chandan B, Gupta PN.
    Mater Sci Eng C Mater Biol Appl; 2014 May 01; 38():85-93. PubMed ID: 24656356
    [Abstract] [Full Text] [Related]

  • 15. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC, Lin PI, Wang CC.
    Nanomedicine (Lond); 2011 Aug 01; 6(6):1011-26. PubMed ID: 21707298
    [Abstract] [Full Text] [Related]

  • 16. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
    Tran TH, Nguyen TD, Van Nguyen H, Nguyen HT, Kim JO, Yong CS, Nguyen CN.
    Arch Pharm Res; 2016 May 01; 39(5):687-94. PubMed ID: 27015824
    [Abstract] [Full Text] [Related]

  • 17. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L, Hou L, Guo D, Xiao X, Mao P, Yang X.
    Int J Pharm; 2012 Oct 15; 436(1-2):815-24. PubMed ID: 22846410
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.